TY - JOUR
T1 - Health Resource Use in Survivors of Pediatric Septic Shock in the United States
AU - Maddux, Aline B.
AU - Zimmerman, Jerry J.
AU - Banks, Russell K.
AU - Reeder, Ron W.
AU - Meert, Kathleen L.
AU - Czaja, Angela S.
AU - Berg, Robert A.
AU - Sapru, Anil
AU - Carcillo, Joseph A.
AU - Newth, Christopher J.L.
AU - Quasney, Michael W.
AU - Mourani, Peter M.
N1 - Funding Information:
Supported, in part, by the Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Department of Health and Human Services, R01HD073362 (to Dr. Zimmerman), and, in part, by the following cooperative agreements associated with the Collaborative Pediatric Critical Care Research Network: UG1HD050096 (Meert), UG1HD049981, UG1HD049983, UG1HD063108, UG1HD083171 (Mourani), UG1HD083166, UG1HD083170, U10HD050012, U10HD063106, and U01HD049934. Also supported, in part, by R03HD104001 (to Dr. Reeder), K23HD096018 (to Dr. Maddux), and the Francis Family Foundation (to Dr. Maddux).
Funding Information:
Dr. Maddux’s institution received funding from the National Institute of Child Health and Human Development (NICHD) (K23HD096018) and the Francis Family Foundation. Drs. Maddux, Zimmerman, Banks, Reeder, Meert, Berg, Sapru, Carcillo, Newth, and Mourani received support for article research from the National Institutes of Health (NIH). Drs. Zimmerman’s, Banks’, and Carcillo’s institution received funding from the NICHD. Dr. Zimmerman’s institution received funding from Immunexpress; he received funding from Elsevier Publishing. Dr. Banks disclosed government work. Drs. Reeder’s, Meert’s, Berg’s, Sapru’s, Newth’s, and Mourani’s institutions received funding from the NIH. Dr. Czaja disclosed that she is a member of the critical care subboard for the American Board of Pediatrics. Dr. Carcillo’s institution received funding from the National Institute of General Medical Sciences. Dr. Newth received funding from Philips Research North America and Nihon Kohden. Dr. Mourani received funding from the NICHD (UG1HD083171). Dr. Quasney has disclosed that he does not have any potential conflicts of interest.
Publisher Copyright:
© 2022 Lippincott Williams and Wilkins. All rights reserved.
PY - 2022/6/1
Y1 - 2022/6/1
N2 - OBJECTIVES: To evaluate postdischarge health resource use in pediatric survivors of septic shock and determine patient and hospitalization factors associated with health resource use. DESIGN Secondary analyses of a multicenter prospective observational cohort study. SETTING: Twelve academic PICUs. PATIENTS: Children greater than or equal to 1 month and less than 18 years old hospitalized for community-acquired septic shock who survived to 1 year. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: For 308/338 patients (91%) with baseline and greater than or equal to one postdischarge survey, we evaluated readmission, emergency department (ED) visits, new medication class, and new device class use during the year after sepsis. Using negative binomial regression with bidirectional stepwise selection, we identified factors associated with each outcome. Median age was 7 years (interquartile range, 2-13), 157 (51%) had a chronic condition, and nearly all patients had insurance (private [n = 135; 44%] or government [n = 157; 51%]). During the year after sepsis, 128 patients (42%) were readmitted, 145 (47%) had an ED visit, 156 (51%) started a new medication class, and 102 (33%) instituted a new device class. Having a complex chronic condition was independently associated with readmission and ED visit. Documented infection and higher sum of Pediatric Logistic Organ Dysfunction - 2 hematologic score were associated with readmission, whereas younger age and having a noncomplex chronic condition were associated with ED visit. Factors associated with new medication class use were private insurance, neurologic insult, and longer PICU stays. Factors associated with new device class use were preadmission chemotherapy or radiotherapy, presepsis Functional Status Scale score, and ventilation duration greater than or equal to 10 days. Of patients who had a new medication or device class, most had a readmission (56% and 61%) or ED visit (62% and 67%). CONCLUSIONS: Children with septic shock represent a high-risk cohort with high-resource needs after discharge. Interventions and targeted outcomes to mitigate postdischarge resource use may differ based on patients' preexisting conditions.
AB - OBJECTIVES: To evaluate postdischarge health resource use in pediatric survivors of septic shock and determine patient and hospitalization factors associated with health resource use. DESIGN Secondary analyses of a multicenter prospective observational cohort study. SETTING: Twelve academic PICUs. PATIENTS: Children greater than or equal to 1 month and less than 18 years old hospitalized for community-acquired septic shock who survived to 1 year. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: For 308/338 patients (91%) with baseline and greater than or equal to one postdischarge survey, we evaluated readmission, emergency department (ED) visits, new medication class, and new device class use during the year after sepsis. Using negative binomial regression with bidirectional stepwise selection, we identified factors associated with each outcome. Median age was 7 years (interquartile range, 2-13), 157 (51%) had a chronic condition, and nearly all patients had insurance (private [n = 135; 44%] or government [n = 157; 51%]). During the year after sepsis, 128 patients (42%) were readmitted, 145 (47%) had an ED visit, 156 (51%) started a new medication class, and 102 (33%) instituted a new device class. Having a complex chronic condition was independently associated with readmission and ED visit. Documented infection and higher sum of Pediatric Logistic Organ Dysfunction - 2 hematologic score were associated with readmission, whereas younger age and having a noncomplex chronic condition were associated with ED visit. Factors associated with new medication class use were private insurance, neurologic insult, and longer PICU stays. Factors associated with new device class use were preadmission chemotherapy or radiotherapy, presepsis Functional Status Scale score, and ventilation duration greater than or equal to 10 days. Of patients who had a new medication or device class, most had a readmission (56% and 61%) or ED visit (62% and 67%). CONCLUSIONS: Children with septic shock represent a high-risk cohort with high-resource needs after discharge. Interventions and targeted outcomes to mitigate postdischarge resource use may differ based on patients' preexisting conditions.
KW - child
KW - critical care outcome
KW - hospital readmission; intensive care units
KW - medical device
KW - pediatric
KW - septic shock
UR - http://www.scopus.com/inward/record.url?scp=85132453250&partnerID=8YFLogxK
U2 - 10.1097/PCC.0000000000002932
DO - 10.1097/PCC.0000000000002932
M3 - Article
C2 - 35250001
AN - SCOPUS:85132453250
SN - 1529-7535
VL - 23
SP - E277-E288
JO - Pediatric Critical Care Medicine
JF - Pediatric Critical Care Medicine
IS - 6
ER -